What makes Ligand Pharmaceuticals (LGND) an investment option?
Summers Value Partners, an investment management firm, released its Q3 2025 investor letter. A copy of the letter can be downloaded here. The Summers Value Fund LP returned a net 20.4% return in the third quarter of 2025, outperforming the 12.4% return of the Russell 2000 Index ETF (IWM) and the 12.5% ​​return of the…